Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 4, 1997, Pages 309-317

  Harasym, Troy O ^a   Cullis, Pieter R ^b   Bally, Marcel B ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Doxorubicin; Extravasation; Liposomes

Indexed keywords

ANTIBODY; CD11B ANTIGEN; CHOLESTEROL; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; LIPOSOME; PHOSPHATIDYLCHOLINE; RADIOISOTOPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES TUMOR; CANCER GRAFT; CELL SUSPENSION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG TISSUE LEVEL; ENCAPSULATION; FEMALE; FLUORESCENCE MICROSCOPY; FLUOROMETRY; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA L 1210; LEWIS CARCINOMA; MACROPHAGE; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TISSUE DISTRIBUTION; TUMOR; TUMOR ASSOCIATED LEUKOCYTE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, LEWIS LUNG; CHOLESTEROL; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; INJECTIONS, INTRAVENOUS; LEUKEMIA L1210; LIPOSOMES; MACROPHAGE-1 ANTIGEN; MELANOMA, EXPERIMENTAL; MICE; PHOSPHATIDYLCHOLINES; TISSUE DISTRIBUTION;

EID: 0030977633     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050662     Document Type: Article

References (28)

1. Allen TM, Chonn A (1987) Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett 223:42
2. Bakker-Woudenberg IA, Lakerse AF, ten-Kate MT, Storm G (1992) Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. Biochim Biophys Acta 1138:318
3. Balazsovits JA, Mayer LD, Bally MB, Cullis PR, McDonell M, Ginsberg RS, Falk RE (1989) Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother Pharmacol 23:81
4. Bally MB, Nayar R, Masin D, Hope MJ, Cullis PR, Mayer LD (1990) Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta 1023:133
5. Bally MB, Masin D, Nayar R, Cullis PR, Mayer LD (1994) Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor bearing mice. Cancer Chemother Pharmacol 34:137
6. Broxterman HJ, Feller N, Kuiper CM, Boven E, Versantvoort CH, Teerlink T, Pinedo HM, Lankelma J (1995) Correlation between functional and molecular analysis of mdrl P-glycoprotein in human solid-tumor xenografts. Int J Cancer 61:880
7. Gabizon A (1992) Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52:891
8. Gabizon A, Papahadjopoulos D (1988) Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 85:6949
9. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM (1995) Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 13:996
10. Hill RP, Stanley JA (1975) The lung-colony assay: extension to the Lewis lung tumor and the B16 melanoma-radiosensitivity of B16 melanoma cells. Int J Radiat Biol 27:377
11. Hope MJ, Bally MB, Webb G, Cullis PR (1985) Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta 812:55
12. Huang SK, Martin FJ, Jay G, Vogel J, Papahadjopoulos D, Friend DS (1993) Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. Am J Pathol 143:10
13. Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A Papahadjopoulos D (1994) Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 54:2186
14. Kanter PM, Bullard GA, Ginsberg RA, Pilkiewicz FG, Mayer LD, Cullis PR, Pavelic ZP (1993) Comparison of the cardiac effects of liposomal doxorubicin (TLC D-99) versus free doxorubicin in beagle dogs. In Vivo 7:17
15. Kanter PM, Bullard GA, Pilkiewicz FG, Mayer LD, Cullis PR, Pavelic ZP (1993) Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs. In Vivo 7:85
16. Litzinger DC, Buiting AM, van Rooijen N, Huang L (1994) Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta 1190:99
17. Mayer LD, Hope MJ, Cullis PR, Janoff AS (1986) Solute distribution and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta 817:193
18. Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS, Cullis PR, Bally MB (1989) Influence of vesicle size, lipid composition and drug to lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 49:5922
19. Mayer LD, Bally MB, Cullis PR, Wilson SL, Emerman JT (1990) Comparison of free and liposomal encapsulated doxorubicin tumor drug uptake and antitumor efficacy in the SC115 murine mammary tumor. Cancer Lett 53:183
20. Mayer LD, Cullis PR, Bally MB (1994) The use of transmembrane pH gradient-driven drug encapsulation in the pharmacodynamic evaluation of liposomal doxorubicin. J Liposome Res 4:529
21. Nagy JA, Herzberg KT, Masse EM, Zientara GP, Dvorak HF (1989) Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. Cancer Res 49:5448
22. O'Sullivan MM, Powell N, French AP, Williams KE, Morgan JR, Williams BD (1988) Inflammatory joint disease: a comparison of liposome scanning, bone scanning and radiography. Ann Rheum Dis 47:485
23. Storm G, Steerenber PA, Emmen F, van Borssum WM, Crommelin DJ (1988) Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes. Biochim Biophys Acta 965:136
24. Tannock IF (1989) Principles of cell proliferation. Cell kinetics. In: Devita VT, Hellman S, Rosenberg SA (eds) Cancer. Principle and practice of Oncology, 3rd edn. J.B. Lippincott, Philadelphia, p 3
25. Thies RL, Cowens DW, Cullis PR, Bally MB, Mayer LD (1990) Method tor rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma. Anal Biochem 188:65
26. Unezaki S, Maruyama K, Takahashi N, Koyama M, Yuda T, Suginaka A, Iwatsuru M (1994) Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia. Pharm Res 11:1180
27. Warren BA (1979) The vascular morphology of tumors. In: Hans-Inge Peterson (ed) Tumor blood circulation. Angiogenesis, vascular morphology and blood flow of experimental and human tumors. CRC Press, Boca Raton, p 1
28. Wu NZ, Da D, Rudoll TL, Needham D, Whorton AR, Dewhirst MW (1993) Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 53:3765